Stock Research for ACOR

ACOR
Current Price

$25.1500


Latest Update: 2018-01-16 16:00:00

High
$ 25.2000
Low
$ 25.0000
Close
$ 25.0500
Volume
89934
 
  

Featured Broker: TradeStation

Get the due diligence for another stock.

 

ACOR Stock Chart & Research Data

The ACOR chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the ACOR chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


 


ACOR Due diligence Resources & Stock Charts

The ACOR stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View ACOR Detailed Price Forecast - CNN Money CNN View ACOR Detailed Summary - Google Finance
Yahoo View ACOR Detailed Summary - Yahoo! Finance Zacks View ACOR Stock Research & Analysis - Zacks.com


Stock Analysis

TradeIdeas View ACOR Trends & Analysis - Trade-Ideas Barrons View ACOR Major Holders - Barrons
NASDAQ View ACOR Call Transcripts - NASDAQ Seeking View ACOR Breaking News & Analysis - Seeking Alpha
Spotlight View ACOR Annual Report - CompanySpotlight.com OTC Report View ACOR OTC Short Report - OTCShortReport.com
TradeKing View ACOR Fundamentals - TradeKing Charts View ACOR SEC Filings - Bar Chart
WSJ View Historical Prices for ACOR - The WSJ Morningstar View Performance/Total Return for ACOR - Morningstar
MarketWatch View the Analyst Estimates for ACOR - MarketWatch CNBC View the Earnings History for ACOR - CNBC
StockMarketWatch View the ACOR Earnings - StockMarketWatch MacroAxis View ACOR Buy or Sell Recommendations - MacroAxis
Bullish View the ACOR Bullish Patterns - American Bulls Short Pains View ACOR Short Pain Metrics - ShortPainBot.com


Social Media Mentions

StockTwits View ACOR Stock Mentions - StockTwits PennyStocks View ACOR Stock Mentions - PennyStockTweets
Twitter View ACOR Stock Mentions - Twitter Invest Hub View ACOR Investment Forum News - Investor Hub
Yahoo View ACOR Stock Mentions - Yahoo! Message Board Seeking Alpha View ACOR Stock Mentions - Seeking Alpha




Financial & Transaction Holdings

SECform4 View Insider Transactions for ACOR - SECform4.com Insider Cow View Insider Transactions for ACOR - Insider Cow
CNBC View ACOR Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for ACOR - OTC Markets
Yahoo View Insider Transactions for ACOR - Yahoo! Finance NASDAQ View Institutional Holdings for ACOR - NASDAQ


Stock Charts

FinViz View ACOR Stock Insight & Charts - FinViz.com StockCharts View ACOR Investment Charts - StockCharts.com
BarChart View ACOR Stock Overview & Charts - BarChart Trading View View ACOR User Generated Charts - Trading View


Latest Financial News for ACOR

DEADLINE TOMORROW: Levi & Korsinsky, LLP Reminds Shareholders of Acorda Therapeutics, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of January 17, 2018 - ACOR
Posted on Tuesday January 16, 2018

NEW YORK, NY / ACCESSWIRE / January 16, 2018 / The following statement is being issued by Levi & Korsinsky, LLP: To: All persons or entities who purchased or otherwise acquired securities of Acorda Therapeutics, ...


FINAL DEADLINE ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Acorda Therapeutics, Inc. (ACOR) & Lead Plaintiff Deadline - January 17, 2018
Posted on Tuesday January 16, 2018

NEW YORK, NY / ACCESSWIRE / January 16, 2018 / Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against Acorda Therapeutics, Inc. ("Acorda" or the ...


ACOR UPCOMING DEADLINE: The Law Offices of Vincent Wong Reminds Investors of Commencement of a Class Action Involving Acorda Therapeutics, Inc. and a Lead Plaintiff Deadline of January 17, 2018
Posted on Monday January 15, 2018

NEW YORK, NY / ACCESSWIRE / January 15, 2018 / The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the United States District Court for the Southern District of New ...


IMPORTANT STOCKHOLDER NOTICE: Brodsky & Smith, LLC Reminds Acorda Therapeutics, Inc. (ACOR) Stockholders That Important Deadline Nears
Posted on Monday January 15, 2018

BALA CYNWYD, PA / ACCESSWIRE / January 15, 2018 / On behalf of the law office of Brodsky & Smith, LLC, notice is hereby given that a class action lawsuit has been filed in the United States District Court ...


A New Kind of Stock Chart: Acorda Therapeutics Inc (NASDAQ:ACOR) Critical ...
CML News - Aug 11, 2016
This is a real time view of the critical technical pivot points for Acorda Therapeutics Inc (NASDAQ:ACOR) . The technical pivot points we look at all surround the stock price movement from the last 10-trading days through the last year.

Acorda Therapeutics Exploring a Potential Sale
Wall Street Journal - Jan 5, 2018
Biotechnology company Acorda Therapeutics Inc. ACOR 0.98% is exploring a potential sale, according to people familiar with the matter.

ACOR ALERT: Rosen Law Firm Reminds Acorda Therapeutics, Inc. Investors of ...
GlobeNewswire (press release) - Jan 11, 2018
NEW YORK, Jan. 11, 2018 (GLOBE NEWSWIRE) -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Acorda Therapeutics, Inc. (NASDAQ:ACOR) from April 18, 2016 through November 14, 2017, inclusive (the “Class Period ...

Acorda up 12% on potential sale
Seeking Alpha - Jan 5, 2018
The WSJ reports that Acorda Therapeutics (ACOR +11.9%) is exploring a potential sale. The company has been facing generic competition for top seller Ampyra (dalfampridine) since the USPTO invalidated several key patents earlier this year.
Acorda Therapeutics Inc. (ACOR) Soars 11.88% on January 05 - Equities.com
Acorda Therapeutics exploring sale: WSJ - Reuters

Enter a stock symbol to view the stock details.